SlideShare une entreprise Scribd logo
1  sur  4
Télécharger pour lire hors ligne
EXPLOIT NATURAL BIOVIDERSITY
FOR LEADING HEALTH PRODUCTS
NUTRACEUTICAL
 Analytical Services
 Research & Development Services
 Bio-Bank Services
The problem-solving
for nutraceuticals
Microbionoffersoutstandingcustom-tailoredservicesforacomprehensivegenomicanalysis
of microorganisms for direct use (e.g. probiotics in tablets) or for the fermentations of food
matrices (e.g. fermented milk).
In particular Microbion analyses and advises on:
	 genetic stability of industrial strains;
	 purity and viability of strain’s batch;
	 geneticfeaturesrelatedtopossibleconsumerrisk;
	 scientific bases to reinforce and extend health claims;
	 genetic markers for strain tracking and authentication for batches validation;
	 strain-specific diagnostics in order to allow strain recognition in clinical trials.
As research-based consultancy, Microbion in constantly updating its methodology in order
to provide solutions developed on customer’s needs in compliance with regulatory body gui-
delines (e.g. EFSA, EMA,FDA).
Thanks to innovative molecular technologies based on DNA, Microbion is able to uncover
genetic features of microbial strains, giving a tremendous advantage to its customers for:
 product development;
 health claims authorization;
 quality assurance.
Application of innovative
molecular microbiology has
never been so user-friendly. We
design and perform scientific
projects according to specific
customers’ needs. Tell us what
is your aim and Microbion will
lead you to it, in the most cost-
effective manner.
Some of our services for
nutraceuticals industry
What is it?
An analysis based on genetic and phenotypic assays for strain safety assessment and strain
characterization in relation to health claims.
What does it do?
It can include complete genome sequencing, assembly and annotation for analysis of whole
DNA content and/or gene specific assays targeted on key molecular markers.
When is it needed?
In the development of the new products based on microbial strains, for selection of best per-
forming candidate strains and for regulatory compliance.
Genomic assessment
What is it?
A genetic analysis for the identification of strains based on comparison with reference strains
(e.g. master cell bank) genetic profile.
What does it do?
Using DNA fingerprinting technology, it allows to prove the identity and genetic stability of
isolates by comparison of their genetic profile obtained with different approaches of mole-
cular characterization.
When is it needed?
> For the validation of product batches;
> During process optimization projects, in order to track back a source of contamination;
> In order to monitor outsourced manufacturing;
> In case of disputes with competitors about strain ownership.
RELIABLE STRAIN AUTHENTICATION AND TRACKING
1
2
What is it?
A service for the screening of collection strains, or selection of new strains and backup de-
posit.
What does it do?
Microbion has a vast collection of lactic acid bacteria and yeast, which is constantly increa-
sing, where you can find your next probiotic strain. In accordance with a Material Transfer
Agreement, Microbion can manage your safe-deposit procedure at the International Depo-
sitory Authorities and also store your strains, or any microbial isolate, in our facility in order
to keep them viable for later use.
When is it needed?
During product development for the selection of novel strains. It can provide also compliance
with regulatory guidelines when reference sample need to be stored for a long time.
In addition to the authentication service it is the ideal solution in case of contamination of
loss of industrial strains.
What is it?
A program for the development of diagnostic methods and protocols designed specifically on
your strain or product formulation.
What does it do?
According with the customer need, Microbion can develop new innovative analytical proto-
col or adapt current ones to achieve the best performance with specific strains and specific
formulations including complex food products.
When is it needed?
It is extremely helpful in the design of clinical trials, in order to unambiguously distinguish
your strains from competitors and natural occurring ones.
3
4
BIO-BANK SERVICES
diagnostic development
microbion.it
Microbion S.R.L.
Strada Le Grazie, 15 (Ca’Vignal 2) – 37134 Verona
Tel. (+39) 045 8027930 – Fax. (+39) 045 8027051
Email: info@microbion.it
P.IVA 04045090232
agenziatecnodue.com
Other industries covered:
Oenology – Beer – Vinegar
Dairy
Pharma
Cured and fresh meat and eggs
Bakery products
Ready-to-eat products
Zootechnics - Feeds
Food Conserve
Environmental - Agronomic

Contenu connexe

Tendances

Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene TherapiesTurning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Merck Life Sciences
 
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
MilliporeSigma
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
MilliporeSigma
 
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
MilliporeSigma
 

Tendances (17)

Strategies for Effective Bioburden and Aseptic Control
Strategies for Effective Bioburden and Aseptic ControlStrategies for Effective Bioburden and Aseptic Control
Strategies for Effective Bioburden and Aseptic Control
 
Learn about the latest innovations at MilliporeSigma
Learn about the latest innovations at MilliporeSigmaLearn about the latest innovations at MilliporeSigma
Learn about the latest innovations at MilliporeSigma
 
Demonstrating Process Scalability with Robust and Turnkey Platforms
Demonstrating Process Scalability with Robust and Turnkey PlatformsDemonstrating Process Scalability with Robust and Turnkey Platforms
Demonstrating Process Scalability with Robust and Turnkey Platforms
 
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene TherapiesTurning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
 
Q5 c step4
Q5 c step4Q5 c step4
Q5 c step4
 
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
 
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic TherapeuticsRapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
 
Holistic Approaches to Virus Risk Mitigation
Holistic Approaches to Virus Risk MitigationHolistic Approaches to Virus Risk Mitigation
Holistic Approaches to Virus Risk Mitigation
 
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...
 
QBD for Downstream Virus Filtration
QBD for Downstream Virus FiltrationQBD for Downstream Virus Filtration
QBD for Downstream Virus Filtration
 
Latest Updates in Biosafety Testing for Gene Therapy
Latest Updates in Biosafety Testing for Gene TherapyLatest Updates in Biosafety Testing for Gene Therapy
Latest Updates in Biosafety Testing for Gene Therapy
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
 
Accelerating Rapid Diagnostics
Accelerating Rapid DiagnosticsAccelerating Rapid Diagnostics
Accelerating Rapid Diagnostics
 
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
 
Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...
Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...
Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...
 
Endotoxin Control and Clearance in Biomanufacturing
Endotoxin Control and Clearance in BiomanufacturingEndotoxin Control and Clearance in Biomanufacturing
Endotoxin Control and Clearance in Biomanufacturing
 
Cell Culture Media Filtration – Evaluating Cell Culture Performance
Cell Culture Media Filtration – Evaluating Cell Culture PerformanceCell Culture Media Filtration – Evaluating Cell Culture Performance
Cell Culture Media Filtration – Evaluating Cell Culture Performance
 

En vedette

Double page spread photos pro
Double page spread photos proDouble page spread photos pro
Double page spread photos pro
shania1999
 
Analysis of Cover, Double Page Spread & Contents Page
Analysis of Cover, Double Page Spread & Contents Page Analysis of Cover, Double Page Spread & Contents Page
Analysis of Cover, Double Page Spread & Contents Page
shania1999
 
Evaluation Questions 6 & 7
Evaluation Questions 6 & 7Evaluation Questions 6 & 7
Evaluation Questions 6 & 7
shania1999
 
Evaluation question 1
Evaluation question 1Evaluation question 1
Evaluation question 1
shania1999
 

En vedette (14)

Sec intro1
Sec intro1Sec intro1
Sec intro1
 
Evaluation
Evaluation   Evaluation
Evaluation
 
Preliminary evaluation
Preliminary evaluationPreliminary evaluation
Preliminary evaluation
 
Seguridad informática
Seguridad informáticaSeguridad informática
Seguridad informática
 
Double page spread photos pro
Double page spread photos proDouble page spread photos pro
Double page spread photos pro
 
Iso 2858 end suction centrifugal pumps (16 bar)
Iso 2858   end suction centrifugal pumps (16 bar)Iso 2858   end suction centrifugal pumps (16 bar)
Iso 2858 end suction centrifugal pumps (16 bar)
 
Questionnaire results
Questionnaire resultsQuestionnaire results
Questionnaire results
 
Analysis of Cover, Double Page Spread & Contents Page
Analysis of Cover, Double Page Spread & Contents Page Analysis of Cover, Double Page Spread & Contents Page
Analysis of Cover, Double Page Spread & Contents Page
 
Audience profile
Audience profileAudience profile
Audience profile
 
Questionnaire results
Questionnaire resultsQuestionnaire results
Questionnaire results
 
Child labour "A CURSE"
Child labour "A CURSE"Child labour "A CURSE"
Child labour "A CURSE"
 
Evaluation Questions 6 & 7
Evaluation Questions 6 & 7Evaluation Questions 6 & 7
Evaluation Questions 6 & 7
 
Evaluation question 1
Evaluation question 1Evaluation question 1
Evaluation question 1
 
Plastic manufacturing "forming and shaping plastics"
Plastic manufacturing "forming and shaping plastics"Plastic manufacturing "forming and shaping plastics"
Plastic manufacturing "forming and shaping plastics"
 

Similaire à Microbion_nutraceuticals_emailing

Jamal Almustapha Resume 08-2015
Jamal Almustapha Resume 08-2015Jamal Almustapha Resume 08-2015
Jamal Almustapha Resume 08-2015
Jamal Almustapha
 
Biopharmaceutical and cell therapy products
Biopharmaceutical and cell therapy productsBiopharmaceutical and cell therapy products
Biopharmaceutical and cell therapy products
Keaty More
 
Cell based assays (2010)
Cell based assays (2010)Cell based assays (2010)
Cell based assays (2010)
jaayboy69
 
Cell Based Assays (2010) Ella
Cell Based Assays (2010) EllaCell Based Assays (2010) Ella
Cell Based Assays (2010) Ella
Elakeche
 
Biodextris Presentation - New client presentation
Biodextris Presentation - New client presentationBiodextris Presentation - New client presentation
Biodextris Presentation - New client presentation
Joseph Zimmermann
 

Similaire à Microbion_nutraceuticals_emailing (20)

Bio outsource services
Bio outsource servicesBio outsource services
Bio outsource services
 
Strategies for Effective Bioburden and Aseptic Control
Strategies for Effective Bioburden and Aseptic ControlStrategies for Effective Bioburden and Aseptic Control
Strategies for Effective Bioburden and Aseptic Control
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Sample Prep Solutions for Microbiome Research
Sample Prep Solutions for Microbiome ResearchSample Prep Solutions for Microbiome Research
Sample Prep Solutions for Microbiome Research
 
The CGC
The CGCThe CGC
The CGC
 
Viral Risk Mitigation - A Global Regulatory Perspective
Viral Risk Mitigation - A Global Regulatory PerspectiveViral Risk Mitigation - A Global Regulatory Perspective
Viral Risk Mitigation - A Global Regulatory Perspective
 
APPLICATIONS of Biotechnology
APPLICATIONS of BiotechnologyAPPLICATIONS of Biotechnology
APPLICATIONS of Biotechnology
 
White Paper : Need for Standardization of Tests for Plant Viruses
White Paper : Need for Standardization of Tests for Plant VirusesWhite Paper : Need for Standardization of Tests for Plant Viruses
White Paper : Need for Standardization of Tests for Plant Viruses
 
Jamal Almustapha Resume 08-2015
Jamal Almustapha Resume 08-2015Jamal Almustapha Resume 08-2015
Jamal Almustapha Resume 08-2015
 
2015 biotek catalog, Iran distributor Viragene Akam co.
2015 biotek catalog, Iran distributor Viragene Akam co.2015 biotek catalog, Iran distributor Viragene Akam co.
2015 biotek catalog, Iran distributor Viragene Akam co.
 
Biopharmaceutical and cell therapy products
Biopharmaceutical and cell therapy productsBiopharmaceutical and cell therapy products
Biopharmaceutical and cell therapy products
 
Biopharmaceutical and cell therapy products
Biopharmaceutical and cell therapy productsBiopharmaceutical and cell therapy products
Biopharmaceutical and cell therapy products
 
Microbiological and Chromogenic Culture Media
Microbiological and Chromogenic Culture MediaMicrobiological and Chromogenic Culture Media
Microbiological and Chromogenic Culture Media
 
Cell based assays (2010)
Cell based assays (2010)Cell based assays (2010)
Cell based assays (2010)
 
Cell Based Assays (2010) Ella
Cell Based Assays (2010) EllaCell Based Assays (2010) Ella
Cell Based Assays (2010) Ella
 
In vitro program
In vitro program In vitro program
In vitro program
 
Adherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptxAdherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptx
 
Biodextris Presentation - New client presentation
Biodextris Presentation - New client presentationBiodextris Presentation - New client presentation
Biodextris Presentation - New client presentation
 
Profile alexandros chatgilialoglu - ey if
Profile   alexandros chatgilialoglu - ey ifProfile   alexandros chatgilialoglu - ey if
Profile alexandros chatgilialoglu - ey if
 

Microbion_nutraceuticals_emailing

  • 1. EXPLOIT NATURAL BIOVIDERSITY FOR LEADING HEALTH PRODUCTS NUTRACEUTICAL  Analytical Services  Research & Development Services  Bio-Bank Services
  • 2. The problem-solving for nutraceuticals Microbionoffersoutstandingcustom-tailoredservicesforacomprehensivegenomicanalysis of microorganisms for direct use (e.g. probiotics in tablets) or for the fermentations of food matrices (e.g. fermented milk). In particular Microbion analyses and advises on:  genetic stability of industrial strains;  purity and viability of strain’s batch;  geneticfeaturesrelatedtopossibleconsumerrisk;  scientific bases to reinforce and extend health claims;  genetic markers for strain tracking and authentication for batches validation;  strain-specific diagnostics in order to allow strain recognition in clinical trials. As research-based consultancy, Microbion in constantly updating its methodology in order to provide solutions developed on customer’s needs in compliance with regulatory body gui- delines (e.g. EFSA, EMA,FDA). Thanks to innovative molecular technologies based on DNA, Microbion is able to uncover genetic features of microbial strains, giving a tremendous advantage to its customers for:  product development;  health claims authorization;  quality assurance. Application of innovative molecular microbiology has never been so user-friendly. We design and perform scientific projects according to specific customers’ needs. Tell us what is your aim and Microbion will lead you to it, in the most cost- effective manner.
  • 3. Some of our services for nutraceuticals industry What is it? An analysis based on genetic and phenotypic assays for strain safety assessment and strain characterization in relation to health claims. What does it do? It can include complete genome sequencing, assembly and annotation for analysis of whole DNA content and/or gene specific assays targeted on key molecular markers. When is it needed? In the development of the new products based on microbial strains, for selection of best per- forming candidate strains and for regulatory compliance. Genomic assessment What is it? A genetic analysis for the identification of strains based on comparison with reference strains (e.g. master cell bank) genetic profile. What does it do? Using DNA fingerprinting technology, it allows to prove the identity and genetic stability of isolates by comparison of their genetic profile obtained with different approaches of mole- cular characterization. When is it needed? > For the validation of product batches; > During process optimization projects, in order to track back a source of contamination; > In order to monitor outsourced manufacturing; > In case of disputes with competitors about strain ownership. RELIABLE STRAIN AUTHENTICATION AND TRACKING 1 2
  • 4. What is it? A service for the screening of collection strains, or selection of new strains and backup de- posit. What does it do? Microbion has a vast collection of lactic acid bacteria and yeast, which is constantly increa- sing, where you can find your next probiotic strain. In accordance with a Material Transfer Agreement, Microbion can manage your safe-deposit procedure at the International Depo- sitory Authorities and also store your strains, or any microbial isolate, in our facility in order to keep them viable for later use. When is it needed? During product development for the selection of novel strains. It can provide also compliance with regulatory guidelines when reference sample need to be stored for a long time. In addition to the authentication service it is the ideal solution in case of contamination of loss of industrial strains. What is it? A program for the development of diagnostic methods and protocols designed specifically on your strain or product formulation. What does it do? According with the customer need, Microbion can develop new innovative analytical proto- col or adapt current ones to achieve the best performance with specific strains and specific formulations including complex food products. When is it needed? It is extremely helpful in the design of clinical trials, in order to unambiguously distinguish your strains from competitors and natural occurring ones. 3 4 BIO-BANK SERVICES diagnostic development microbion.it Microbion S.R.L. Strada Le Grazie, 15 (Ca’Vignal 2) – 37134 Verona Tel. (+39) 045 8027930 – Fax. (+39) 045 8027051 Email: info@microbion.it P.IVA 04045090232 agenziatecnodue.com Other industries covered: Oenology – Beer – Vinegar Dairy Pharma Cured and fresh meat and eggs Bakery products Ready-to-eat products Zootechnics - Feeds Food Conserve Environmental - Agronomic